Ryuichi Narazaki

691 total citations
16 papers, 597 citations indexed

About

Ryuichi Narazaki is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Ryuichi Narazaki has authored 16 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 5 papers in Oncology. Recurrent topics in Ryuichi Narazaki's work include Drug Solubulity and Delivery Systems (7 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Ryuichi Narazaki is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Ryuichi Narazaki collaborates with scholars based in Japan, United States and Denmark. Ryuichi Narazaki's co-authors include Samuel H. Yalkowsky, Ritesh Sanghvi, Takayuki Ohwaki, Tsutomu Harada, Masaki Otagiri, Stephen G. Machatha, Toru Maruyama, Masaki Otagiri, Kumiko Harada and Yoshiteru Kato and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Molecular Pharmaceutics.

In The Last Decade

Ryuichi Narazaki

16 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuichi Narazaki Japan 12 253 175 120 114 108 16 597
Hakaru Seo Japan 13 189 0.7× 160 0.9× 69 0.6× 94 0.8× 66 0.6× 36 511
Masanori Kayano Japan 15 181 0.7× 341 1.9× 104 0.9× 327 2.9× 72 0.7× 38 780
Hidetoshi Ushio Japan 9 210 0.8× 88 0.5× 93 0.8× 123 1.1× 113 1.0× 23 556
Hatsumi Aki Japan 16 366 1.4× 113 0.6× 86 0.7× 153 1.3× 116 1.1× 62 712
Stephanie A. Sweetana United States 10 115 0.5× 161 0.9× 38 0.3× 37 0.3× 92 0.9× 12 531
Kimberley A. Lentz United States 14 199 0.8× 323 1.8× 136 1.1× 139 1.2× 305 2.8× 24 963
D. Franchi Italy 7 144 0.6× 256 1.5× 162 1.4× 111 1.0× 25 0.2× 12 595
Vadlamani K. Prasad United States 17 132 0.5× 195 1.1× 78 0.7× 163 1.4× 40 0.4× 53 701
Jinyang Hong United States 11 219 0.9× 127 0.7× 88 0.7× 113 1.0× 26 0.2× 12 535
David E. Guttman United States 16 370 1.5× 99 0.6× 84 0.7× 290 2.5× 94 0.9× 36 945

Countries citing papers authored by Ryuichi Narazaki

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Narazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Narazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Narazaki more than expected).

Fields of papers citing papers by Ryuichi Narazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Narazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Narazaki. The network helps show where Ryuichi Narazaki may publish in the future.

Co-authorship network of co-authors of Ryuichi Narazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Narazaki. A scholar is included among the top collaborators of Ryuichi Narazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Narazaki. Ryuichi Narazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Harada, Tsutomu, Ryuichi Narazaki, Takayuki Ohwaki, & Takahiro Uchida. (2010). Effect of physical properties of orally disintegrating tablets on disintegration time as determined by a new apparatus. Journal of Drug Delivery Science and Technology. 20(5). 377–383. 11 indexed citations
2.
Harada, Tsutomu, Takahiro Uchida, Miyako Yoshida, et al.. (2010). A New Method for Evaluating the Bitterness of Medicines in Development Using a Taste Sensor and a Disintegration Testing Apparatus. Chemical and Pharmaceutical Bulletin. 58(8). 1009–1014. 59 indexed citations
3.
Sanghvi, Ritesh, Ryuichi Narazaki, Stephen G. Machatha, & Samuel H. Yalkowsky. (2008). Solubility Improvement of Drugs using N-Methyl Pyrrolidone. AAPS PharmSciTech. 9(2). 366–376. 123 indexed citations
4.
Sanghvi, Ritesh, Erik Mogalian, Stephen G. Machatha, et al.. (2008). Preformulation and pharmacokinetic studies on antalarmin: A novel stress inhibitor. Journal of Pharmaceutical Sciences. 98(1). 205–214. 11 indexed citations
5.
Narazaki, Ryuichi, Ritesh Sanghvi, & Samuel H. Yalkowsky. (2007). Estimation of Drug Precipitation upon Dilution of pH-Cosolvent Solubilized Formulations. Chemical and Pharmaceutical Bulletin. 55(8). 1203–1206. 4 indexed citations
6.
Narazaki, Ryuichi, Ritesh Sanghvi, & Samuel H. Yalkowsky. (2007). Estimation of Drug Precipitation upon Dilution of pH-Controlled Formulations. Molecular Pharmaceutics. 4(4). 550–555. 11 indexed citations
7.
Harada, Tsutomu, Ryuichi Narazaki, Shinsuke Nagira, et al.. (2006). Evaluation of the Disintegration Properties of Commercial Famotidine 20 mg Orally Disintegrating Tablets Using a Simple New Test and Human Sensory Test. Chemical and Pharmaceutical Bulletin. 54(8). 1072–1075. 48 indexed citations
8.
Narazaki, Ryuichi, et al.. (2004). A New Method for Disintegration Studies of Rapid Disintegrating Tablet. Chemical and Pharmaceutical Bulletin. 52(6). 704–707. 74 indexed citations
9.
Yamasaki, Keishi, Toru Maruyama, Yasuhiro Tsutsumi, et al.. (1999). Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1432(2). 313–323. 80 indexed citations
10.
Asai, Yasuyuki, et al.. (1999). The Effect of the Lipid A Analog, E5531 on Fever Induced by Endotoxin from Escherichia coli.. Biological and Pharmaceutical Bulletin. 22(4). 432–434. 8 indexed citations
11.
Narazaki, Ryuichi, Hiroshi Watanabe, Toru Maruyama, Ayaka Suenaga, & Masaki Otagiri. (1998). An immunological method for the detection of captopril-protein conjugate. Archives of Toxicology. 72(4). 203–206. 7 indexed citations
12.
Narazaki, Ryuichi & Masaki Otagiri. (1997). Covalent Binding of a Bucillamine Derivative with Albumin in Sera from Healthy Subjects and Patients with Various Diseases. Pharmaceutical Research. 14(3). 351–353. 15 indexed citations
13.
Narazaki, Ryuichi, et al.. (1997). Effect of N-B Transition on the Microenvironment Surrounding 34Cys in Human Serum Albumin.. Biological and Pharmaceutical Bulletin. 20(4). 452–454. 2 indexed citations
14.
Narazaki, Ryuichi, Kumiko Harada, Atsushi Sugii, & Masaki Otagiri. (1997). Kinetic Analysis of the Covalent Binding of Captopril to Human Serum Albumin. Journal of Pharmaceutical Sciences. 86(2). 215–219. 27 indexed citations
15.
Narazaki, Ryuichi, Toru Maruyama, & Masaki Otagiri. (1997). Probing the cysteine 34 residue in human serum albumin using fluorescence techniques. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1338(2). 275–281. 84 indexed citations
16.
Narazaki, Ryuichi, et al.. (1996). Covalent Binding Between Bucillamine Derivatives and Human Serum Albumin. Pharmaceutical Research. 13(9). 1317–1321. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026